Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
基本信息
- 批准号:8370929
- 负责人:
- 金额:$ 76.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAgreementAmputationAnimalsAreaBiochemicalBiopsyBlood specimenCaringCell CountCell physiologyCellsCellular biologyCharacteristicsClinicClinicalClinical ResearchClinical ServicesCohort StudiesCommunitiesDataDebridementDiabetes MellitusDiabetic Foot UlcerDiseaseDistalDocumentationEthicsEventFoot UlcerGoalsHealedHematopoietic Stem Cell MobilizationHomingHyperbaric OxygenHypoxia Inducible FactorImpairmentInstitutesInstitutional Review BoardsInterventionLimb structureLower ExtremityManualsMarylandMeasurementMetabolicMethodsNeuropathyNew YorkOhioPatientsPersonsPharmaceutical PreparationsPopulation StudyProceduresProcessProteinsPublicationsPublishingRecruitment ActivityRefractoryRemunerationsResearchRiskSecureSiteSkin UlcerStem cellsSterile coveringsTechniquesTissue SampleTissuesTreatment ProtocolsUlcerVariantWorkWound Healingbasecommunity based treatmentdiabeticdiabetic patientdiabetic wound healingeffective therapygenetic regulatory proteinhealingimprovedinsightneovascularizationpatient populationresponsestandard carestemsuccesstooltreatment planningwound
项目摘要
DESCRIPTION (provided by applicant): Management of lower extremity neuropathic ulcers in diabetic patients has changed little in the past decade. The healing rate is poor, risk of amputations relatively high, and there is a paucity of objective methods for choosing treatments. We will carry out a multi-center clinical cohort study of circulating and wound margin vasculogenic stem/progenitor cells (SPCs) in diabetic patients undergoing treatment for lower extremity neuropathic ulcers. The goal is to develop simple, quantitative methods that provide guidance on effective treatment choices. Our hypothesis is that an analysis of SPCs number and their biochemical characteristics can predict whether diabetic foot ulcers will heal. The experimental approach is built on the very productive framework used in our preliminary R21 project and recent publication. The four specific aims center on SPCs and their association with traditional methods for assessing diabetic control and wound characteristics. Aims are as follows: (1) Determine whether SPCs mobilization/wound recruitment and hypoxia inducible factor-related processes are associated with wound repair, (2) Assess if wound care practices are associated with SPCs mobilization and SPCs homing to wounds, (3) Determine if variations in SPCs are associated with healing, and (4) Assess whether SPCs differences observed between a healing acute biopsy wound versus the foot ulcer are related to clinical issues such as metabolic status. We will evaluate whether SPCs number and content of several intracellular proteins correlate with wound and disease-related factors and whether these measurements can be used to predict diabetic wound healing.
PUBLIC HEALTH RELEVANCE: We plan to carry out a multi-center clinical cohort study of circulating and wound margin vasculogenic stem/progenitor cells in diabetic patients undergoing treatment for limb-threatening lower extremity neuropathic ulcers. The goal is to develop simple, quantitative methods to assess ulcers that provide guidance on effective treatment choices. Our hypothesis is that an analysis of stem/progenitor cell number and their biochemical characteristics can predict whether diabetic foot ulcers will heal.
描述(由申请人提供):糖尿病患者下肢神经性溃疡的治疗在过去十年中几乎没有变化。治愈率较差,截肢风险较高,缺乏客观的治疗选择方法。我们将对接受下肢神经性溃疡治疗的糖尿病患者的循环和伤口边缘血管生成干/祖细胞(SPC)进行多中心临床队列研究。目标是开发简单的定量方法,为有效的治疗选择提供指导。 我们的假设是,对 SPC 数量及其生化特征的分析可以预测糖尿病足溃疡是否会愈合。该实验方法建立在我们初步 R21 项目和最近出版物中使用的非常高效的框架之上。这四个具体目标集中在 SPC 及其与评估糖尿病控制和伤口特征的传统方法的关联上。目标如下:(1) 确定 SPC 动员/伤口募集和缺氧诱导因子相关过程是否与伤口修复相关,(2) 评估伤口护理实践是否与 SPC 动员和 SPC 归巢伤口相关,(3)确定 SPC 的变化是否与愈合相关,并且 (4) 评估在愈合中的急性活检伤口与足部溃疡之间观察到的 SPC 差异是否与代谢状态等临床问题相关。我们将评估 SPC 的数量和几种细胞内蛋白质的含量是否与伤口和疾病相关因素相关,以及这些测量结果是否可用于预测糖尿病伤口愈合。
公共健康相关性:我们计划对正在接受威胁肢体的下肢神经性溃疡治疗的糖尿病患者的循环和伤口边缘血管生成干细胞/祖细胞进行多中心临床队列研究。目标是开发简单、定量的方法来评估溃疡,为有效的治疗选择提供指导。我们的假设是,对干细胞/祖细胞数量及其生化特征的分析可以预测糖尿病足溃疡是否会愈合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Margolis其他文献
David Margolis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Margolis', 18)}}的其他基金
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
- 批准号:
10296086 - 财政年份:2021
- 资助金额:
$ 76.73万 - 项目类别:
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
- 批准号:
10470869 - 财政年份:2021
- 资助金额:
$ 76.73万 - 项目类别:
Comparative effectiveness of spironolactone versus oral tetracycline-class antibiotics for the treatment of moderate to severe acne in women
螺内酯与口服四环素类抗生素治疗女性中度至重度痤疮的疗效比较
- 批准号:
9815052 - 财政年份:2019
- 资助金额:
$ 76.73万 - 项目类别:
NOS1AP and Capon Associated Impaired Healing in Those with Diabetic Foot Ulcers
NOS1AP 和 Capon 与糖尿病足溃疡患者的愈合受损相关
- 批准号:
9925084 - 财政年份:2018
- 资助金额:
$ 76.73万 - 项目类别:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
患有特应性皮炎的非裔美国人:皮肤屏障和免疫
- 批准号:
9228322 - 财政年份:2016
- 资助金额:
$ 76.73万 - 项目类别:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
患有特应性皮炎的非裔美国人:皮肤屏障和免疫
- 批准号:
9868281 - 财政年份:2016
- 资助金额:
$ 76.73万 - 项目类别:
Stem cell mobilization and diabetic skin ulcers
干细胞动员和糖尿病皮肤溃疡
- 批准号:
8538377 - 财政年份:2012
- 资助金额:
$ 76.73万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Actionable categories of avoidable hospital care among adults with cancer
成人癌症患者可避免住院治疗的可行类别
- 批准号:
10714125 - 财政年份:2023
- 资助金额:
$ 76.73万 - 项目类别:
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
- 批准号:
10677169 - 财政年份:2023
- 资助金额:
$ 76.73万 - 项目类别:
Optimizing the Diagnostic Strategy for Acute Musculoskeletal Infections in Children: Evaluating the Clinical Performance and Comparative Cost of a Noninvasive Diagnostic Technique
优化儿童急性肌肉骨骼感染的诊断策略:评估无创诊断技术的临床表现和比较成本
- 批准号:
10664298 - 财政年份:2023
- 资助金额:
$ 76.73万 - 项目类别:
Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST)
治疗痛风目标血清尿酸与治疗避免症状:随机对照试验 (TRUST)
- 批准号:
10583217 - 财政年份:2023
- 资助金额:
$ 76.73万 - 项目类别:
Contact Pathway Inhibitor to Prevent Vascular Access Failure
接触途径抑制剂以防止血管通路失败
- 批准号:
10604057 - 财政年份:2023
- 资助金额:
$ 76.73万 - 项目类别: